|
regulation of mesenchymal cell proliferation
|
GO_0010464 |
[Any process that modulates the frequency, rate or extent of mesenchymal cell proliferation. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.] |
|
specifically dependent continuant
|
BFO_0000020 |
[b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003])] |
|
fiat object part
|
BFO_0000024 |
|
|
mesenchymal cell proliferation
|
GO_0010463 |
[The multiplication or reproduction of cells, resulting in the expansion of a mesenchymal cell population. A mesenchymal cell is a cell that normally gives rise to other cells that are organized as three-dimensional masses, rather than sheets.] |
|
role
|
BFO_0000023 |
|
|
Beclabuvir
|
NCIT_C114983 |
[A non-nucleoside, polymerase inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (NS5B), a RNA-dependent RNA polymerase, with potential activity against HCV. Upon administration and after intracellular uptake, beclabuvir allosterically binds to the non-catalytic Thumb 1 site of viral HCV NS5B polymerase and causes a decrease in viral RNA synthesis and replication. The HCV NS5B protein is essential for the replication of the viral HCV RNA genome. HCV is a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family.] |
|
DPP4
|
OGG_3000001803 |
|
|
regulation of mitotic metaphase/anaphase transition
|
GO_0030071 |
[Any process that modulates the frequency, rate or extent of the cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin.] |
|
SMAD3
|
OGG_3000004088 |
|
|
TMPRSS2
|
OGG_3000007113 |
|
|
imatinib
|
CHEBI_45783 |
[A benzamide obtained by formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary aromatic amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine. Used (as its mesylate salt) for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours.] |
|
three-dimensional spatial region
|
BFO_0000028 |
|
|
one-dimensional spatial region
|
BFO_0000026 |
|
|
Bat SARS CoV Rp3/2004
|
NCBITaxon_349344 |
|
|
object aggregate
|
BFO_0000027 |
|
|
Bat SARS coronavirus Rp2
|
NCBITaxon_349343 |
|
|
Bat SARS coronavirus Rp1
|
NCBITaxon_349342 |
|
|
Self Care
|
NCIT_C15324 |
[Personal performance of activities or tasks traditionally performed by professional health care providers.] |
|
Abnormal circulating creatine kinase concentration
|
HP_0040081 |
[Any deviation from the normal circulating creatine kinase concentration.] |
|
Abnormality of circulating enzyme level
|
HP_0011021 |
[Aberrant concentration in the blood of any of the proteins that act as catalysts for biological reactions] |